BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38416466)

  • 1. Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway.
    Ghiasvand R; Green AC; Veierød MB; Robsahm TE
    JAMA Dermatol; 2024 Apr; 160(4):402-408. PubMed ID: 38416466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors Associated With First and Second Primary Melanomas in a High-Incidence Population.
    Olsen CM; Pandeya N; Dusingize JC; Neale RE; MacGregor S; Law MH; Whiteman DC;
    JAMA Dermatol; 2023 Jan; 159(1):37-46. PubMed ID: 36416830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Melanoma Detected During Routine Skin Checks and Mortality.
    Watts CG; McLoughlin K; Goumas C; van Kemenade CH; Aitken JF; Soyer HP; Fernandez Peñas P; Guitera P; Scolyer RA; Morton RL; Menzies SW; Caruana M; Kang YJ; Mann GJ; Chakera AH; Madronio CM; Armstrong BK; Thompson JF; Cust AE
    JAMA Dermatol; 2021 Dec; 157(12):1425-1436. PubMed ID: 34730781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance.
    Guitera P; Menzies SW; Coates E; Azzi A; Fernandez-Penas P; Lilleyman A; Badcock C; Schmid H; Watts CG; Collgros H; Liu R; van Kemenade C; Mann GJ; Cust AE
    JAMA Dermatol; 2021 May; 157(5):521-530. PubMed ID: 33729464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
    Ghiasvand R; Robsahm TE; Green AC; Rueegg CS; Weiderpass E; Lund E; Veierød MB
    JAMA Dermatol; 2019 Jan; 155(1):39-49. PubMed ID: 30477003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
    Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
    JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Mortality After a Diagnosis of Melanoma In Situ.
    Patel VR; Roberson ML; Pignone MP; Adamson AS
    JAMA Dermatol; 2023 Jul; 159(7):703-710. PubMed ID: 37285145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of second primary invasive melanoma in Queensland, 1982-2003.
    McCaul KA; Fritschi L; Baade P; Coory M
    Cancer Causes Control; 2008 Jun; 19(5):451-8. PubMed ID: 18167620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.
    Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.
    Gassenmaier M; Stec T; Keim U; Leiter U; Eigentler TK; Metzler G; Garbe C
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):63-70. PubMed ID: 30051517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors of Subsequent Primary Melanomas in Austria.
    Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
    JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
    van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
    Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System.
    Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK
    JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway.
    Robsahm TE; Karagas MR; Rees JR; Syse A
    BMC Cancer; 2014 Mar; 14():210. PubMed ID: 24645632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of second primary cancers after a diagnosis of melanoma.
    Bradford PT; Freedman DM; Goldstein AM; Tucker MA
    Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.
    Moloney FJ; Guitera P; Coates E; Haass NK; Ho K; Khoury R; O'Connell RL; Raudonikis L; Schmid H; Mann GJ; Menzies SW
    JAMA Dermatol; 2014 Aug; 150(8):819-27. PubMed ID: 24964862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Sex-Specific Incidence of Melanoma.
    Olsen CM; Thompson JF; Pandeya N; Whiteman DC
    JAMA Dermatol; 2020 May; 156(5):553-560. PubMed ID: 32211827
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.